Fibroblast Growth Factor-21 in clinical islet transplantation

被引:0
|
作者
Meier, Raphael [1 ]
Niclauss, Nadja [1 ]
Morel, Philippe [1 ]
Demuylder-Mischler, Sandrine [1 ]
Asrih, Mohamed [1 ]
Bosco, Domenico [1 ]
Jornayvaz, Francois [1 ]
Berney, Thierry [1 ]
机构
[1] Geneva Univ Hosp & Med Sch, Visceral & Transplant Surg, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
621.9
引用
收藏
页码:S407 / S407
页数:1
相关论文
共 50 条
  • [1] Role of fibroblast growth factor-21 in alcoholic cardiomyopathy
    Ferrer-Curriu, G.
    Guitart-Mampel, M.
    Garrabou, G.
    Villarroya, F.
    Fernandez-Sola, J.
    Planavila, A.
    CARDIOVASCULAR RESEARCH, 2018, 114 : S31 - S31
  • [2] Fibroblast growth factor-21: A link for glucose homeostasis
    Naderali, Ebrahim K.
    Wong, Christopher
    Hussain, Munir
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2009, 3 (04) : 237 - 239
  • [3] Fibroblast growth factor-21, energy balance and obesity
    Giralt, Marta
    Gavalda-Navarro, Aleix
    Villarroya, Francesc
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 418 : 66 - 73
  • [4] Acromegaly is associated with high fibroblast growth factor-21 levels
    B. S. Yurekli
    N. O. Kutbay
    M. Aksit
    A. Suner
    I. Y. Simsir
    S. Seckiner
    G. U. Kocabas
    G. Bozkaya
    F. Saygili
    Journal of Endocrinological Investigation, 2019, 42 : 53 - 60
  • [5] Fibroblast growth factor-21 attenuates olanzapine induced hyperglycemia
    Jeromson, Stewart
    Medak, Kyle
    Bellucci, Annalaura
    Arbeau, Meagan
    Wright, David
    PHYSIOLOGY, 2023, 38
  • [6] Fibroblast Growth Factor-21 Is a Promising Dietary Restriction Mimetic
    Mendelsohn, Andrew R.
    Larrick, James W.
    REJUVENATION RESEARCH, 2012, 15 (06) : 624 - 628
  • [7] Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases
    Kharitonenkov, Alexei
    Shanafelt, Armen B.
    BIODRUGS, 2008, 22 (01) : 37 - 44
  • [8] Fibroblast growth factor-21: a metabolic regulator or something more?
    Salgado, Joao Victor
    Salgado, Bernardete Jorge
    CLINICAL ENDOCRINOLOGY, 2014, 81 (06) : 938 - 940
  • [9] Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases
    Alexei Kharitonenkov
    Armen B. Shanafelt
    BioDrugs, 2008, 22 : 37 - 44
  • [10] Acromegaly is associated with high fibroblast growth factor-21 levels
    Yurekli, B. S.
    Kutbay, N. O.
    Aksit, M.
    Suner, A.
    Simsir, I. Y.
    Seckiner, S.
    Kocabas, G. U.
    Bozkaya, G.
    Saygili, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (01) : 53 - 60